Measles, Mumps, Rubella (MMR) Vaccine Market Outlook; Merck, GSK, Pfizer, Sanofi Lead Innovation
The global Measles, Mumps, Rubella (MMR) vaccine market is entering a phase of accelerated growth as public health authorities, governments, and international health organizations intensify vaccination campaigns to curb the resurgence of preventable childhood diseases. With measles outbreaks rising in several regions and public health agencies reinforcing the importance of routine...
0 Comments 0 Shares 4 Views